Ash Stevens signs on for Ariad's blockbuster contender

In December, Ariad ($ARIA) won an accelerated FDA approval for Iclusig (ponatinib), a leukemia treatment analysts say could be a blockbuster for the Massachusetts drugmaker. Now, contract manufacturer Ash Stevens has signed on to manufacture the drug's API. Report

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.